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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S12criteria. Any initial disagreement was resolved by discussion or con-
sensus with a third reviewer where necessary.
Inclusion criteria were: a) randomised controlled trials (RCT), pro-
spective cohort studies (PCS) or case control studies (CCS); b) including
adults over 45 years old with knee pain or OA; c) undertaking exercise
or physical activity explicitly over at least three months; and d) meas-
uring a safety related outcome including adverse events, pain, physical
functioning, radiographic or magnetic resonance imaging (MRI) OA
biomarker progression or progression to total knee replacement (TKR).
Included studies were assessed for risk of bias using the Cochrane risk of
bias tool for RCT and the Quality In Prognosis Studies risk of bias tool for
PCS and CCS. Safety data were extracted and analysed by narrative
synthesis.
Results: In total, 8605 unique references were identiﬁed by the search
and 37 primary studies were included in the review. The included
studies were made up of 35 RCT, 1 PCS and 1 CCS, which were under-
taken in 16 different countries and were of variable quality. In total,
7194 older adults with either knee pain or clinical, radiographic and
combined OA diagnoses were included. The 35 RCT investigated a
variety of exercise and physical activity interventions including: walk-
ing, Tai Chi, aerobics, strengthening, ﬂexibility, balance, and exercise in
water, of between three months and two years duration. 15 studies
provided data on adverse events, 35 on pain, 32 physical functioning
and 5 some form of radiographic orMRI biomarker of OA progression. In
terms of safety results, only eight serious adverse events were reported:
one inguinal hernia, ﬁve falls (one of which resulted in a head laceration
injury and one a fractured radius), one participant fractured her foot as a
result of dropping a weight and one had an exacerbation of existing
back pain. Mild adverse events of increase in knee pain occurred in a
minority of individuals in eight RCT. There was no evidence of a stat-
istically signiﬁcant increase in pain, decrease in physical function, or
deterioration in radiographic or MRI ﬁndings (compared to either
control group at follow up orwithin the same group comparing baseline
to post treatment data). The single, moderate risk of bias, CCS inves-
tigated factors associated with OA progression to TKR in Finnish older
adults. It concluded that increasing levels of regular exercise were
associated with less chance of progression when compared to those
who did not carry out regular exercise. The single, high risk of bias, PCS
investigated occupational physical activity exposure in older adult
members of a French energy company. From a set of 10 physical activity
variables, only prolonged exposure to kneeling and squatting activities
(between 1 and 25 years) was associated with severe knee pain
(Adjusted OR 1.4 95% CI 1.04,1.85). Overall risk of bias across studies was
variable with performance, attrition, and reporting bias frequently
being unclear.
Conclusions: This systematic review demonstrates that long-term
exercise and physical activity, lasting three months or more, is safe for
older adults with existing knee pain or OA. Serious adverse events with
exercise are very rare. However, the risk of bias of included studies was
often a concern.
These ﬁndings match existing expert consensus regarding the safety of
exercise and current recommendations for exercise and physical
activity as “core” treatments in clinical guidelines.
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Purpose: One naturally-occurring fragment of aggrecan catabolism is
the 32mer fragment derived from the aggrecan interglobular domain
following cleavage by both ADAMTS and MMP enzymes. The aim of this
study was to determine whether the aggrecan 32mer fragment was
bioactive, and if so, to elucidate the mechanism.
Methods: Mouse femoral head cartilage explants, epiphyseal chon-
drocytes, synovial ﬁbroblasts or peritoneal macrophages were cultured
for 24 hours in the presence of synthetic mouse 32mer (FFGVGGED-
DITIQTVTWPDLELPLPRNVTEGE; Auspep, Australia) or a scrambled
peptide comprising the same amino acids in a random order. Global
gene expression in explants treated with IL-1a or 32mer was compared
on Illumina mouse W6-6_V2 expression beadchips. Thereafter, changesin gene and protein expression were validated in cell and explant cul-
tures by qPCR, IL-6 ELISA and gel zymography.
Results: In the microarray experiment, 32mer-treated cartilage
explants decreased their expression of genes encoding matrix proteins
and increased their expression of pro-inﬂammatory/pro-catabolic
genes. The results showed that the pattern of genes that were up- and
down-regulated by IL-1a and 32mer treatment were strikingly similar.
Validation by qPCR conﬁrmed that the 32mer, but not a scrambled
32mer peptide, regulated gene expression in articular chondrocytes,
peritoneal macrophages and synovial ﬁbroblasts from wildtype mice.
The levels of IL-6 measured by ELISA and gelatinase activity measured
by gel zymography were also signiﬁcantly increased in cells treated
with 32mer or IL-1a, but not the scrambled peptide. The striking cor-
relation in the pattern of genes regulated by IL-1a and 32mer treatment
raised the possibility that IL-1a and the 32mer might share components
of a signalling pathway; for example MyD88 is an essential adaptor
protein for both the IL-1 receptor andmost Toll-like receptors (TLR). We
therefore compared cells from wildtype mice and MyD88 null mice for
the effects of 32mer stimulation and found that neither gene expression
nor levels of IL-6 cytokine were increased in cells harvested from mice
lacking MyD88, suggesting that the 32mer might be an activator of TLR
signalling. We next compared the effect of 32mer treatment on mac-
rophage cell lines derived from wildtype, TLR2 or TLR4 null mice and
found that whereas stimulation with the 32mer was identical in wild-
type and TLR4 null cells, the 32mer failed to signal in TLR2 null cells.
These results strongly suggest that the aggrecan 32mer is a ligand for
TLR2. We next used complementary hydropathy to derive an antigenic
sequence for raising an antibody (aCG11) against a putative 32mer-
binding protein, then used aCG11 immunoafﬁnity chromatography to
isolate the putative 32mer-binding protein from 4M GuHCl extracts of
human OA and juvenile cartilage. Mass spectrometry analyses identi-
ﬁed PRELP, a small leucine-rich repeat proteoglycan, as the major
molecule binding to and eluting from the immunoafﬁnity column in
both samples, and this was conﬁrmed byWestern blotting with aPRELP
antibodies. Decorin and biglycan are also members of the small leucine-
rich repeat proteoglycan family; they are related to PRELP, and both
have been identiﬁed as TLR2 and TLR4 ligands. Further experiments to
resolve the biological role of PRELP in 32mer-mediated TLR activation in
chondrocytes, synovial ﬁbroblasts and macrophages are in progress.
Conclusions: These studies identify the aggrecan 32mer as an endog-
enous activator of TLR2-mediated immunity with the potential to
accelerate inﬂammation and cartilage destruction in vivo.
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Purpose: Here we analyzed the impact of decorin-deﬁciency (Dcn-/-)
on the biomechanical properties of cartilage and the osteoarthritis
development in a mouse model via forced exercise on a treadmill. In
articular cartilage, the small leucine-rich proteoglycan decorin (Dcn) is
located within the interterritorial regions of the extracellular matrix
(ECM), where it is associated with thick, well-banded collagen ﬁbrils.
Inside the ECM, decorin binds and inactivates TGF-b and thereby reg-
ulates the activity of this cytokine, which is known to inﬂuence the
sulfation of glycosaminoglycan (GAG) chains.
Methods: Osteoarthritis (OA) was induced in three month-old Dcn-/-
and WT mice via forced running on a treadmill and the severity was
scored by a modiﬁed Mankin score. To analyze biomechanical proper-
ties, knee cartilage of Dcn-/- mice and wild-type (WT) mice was
examined at different developmental stages by histology, immunohis-
tochemistry, and atomic force microscopy (AFM). The amount of active
TGF-b1 in the supernatant of cultured Dcn-/- andWTchondrocytes was
analyzed by ELISA. Expression of GAGmodifying enzymes was assessed
by semi-quantitative RT-PCR.
